Bempedoic acid use not tied to increased risk of new-onset diabetes: CLEAR Outcomes analysis
USA: Bempedoic acid safely reduces LDL cholesterol levels and the risk of cardiovascular events in statin-intolerant patients with and without diabetes, results from a new CLEAR Outcomes analysis have revealed. The use of bempedoic acid over 3.4 years of follow-up in patients without diabetes did not lead to an increase in new-onset diabetes or worsening […]